实用皮肤病学杂志
實用皮膚病學雜誌
실용피부병학잡지
Journal of Practical Dermatology
2015年
5期
321-323
,共3页
王召阳%张立新%徐子刚%向欣%马琳
王召暘%張立新%徐子剛%嚮訢%馬琳
왕소양%장립신%서자강%향흔%마림
银屑病,脓疱性,泛发性%阿维A%儿童
銀屑病,膿皰性,汎髮性%阿維A%兒童
은설병,농포성,범발성%아유A%인동
Psoriasis,pustular,generalized%Acitretin%Children
目的:探讨阿维A治疗儿童泛发性脓疱性银屑病的有效性及安全性。方法回顾性分析应用阿维A治疗18例泛发性脓疱性银屑病患儿的临床资料及随访情况。结果阿维A治疗的有效率为100%,50%的患儿于用药1个月达到临床痊愈,起效时间为1~2周。不良反应以皮肤瘙痒及黏膜干燥最为常见(77.8%),其次为肝酶异常(33.3%)、血脂升高(33.3%)、甲脆性增加及甲沟炎(16.7%)、脱发(5.6%),随访期间未发现骨骼系统异常。复发原因以感染最为常见。结论阿维A治疗儿童泛发性脓疱性银屑病疗效好,安全性高,可以作为治疗儿童泛发性脓疱性银屑病的首选药物。
目的:探討阿維A治療兒童汎髮性膿皰性銀屑病的有效性及安全性。方法迴顧性分析應用阿維A治療18例汎髮性膿皰性銀屑病患兒的臨床資料及隨訪情況。結果阿維A治療的有效率為100%,50%的患兒于用藥1箇月達到臨床痊愈,起效時間為1~2週。不良反應以皮膚瘙癢及黏膜榦燥最為常見(77.8%),其次為肝酶異常(33.3%)、血脂升高(33.3%)、甲脆性增加及甲溝炎(16.7%)、脫髮(5.6%),隨訪期間未髮現骨骼繫統異常。複髮原因以感染最為常見。結論阿維A治療兒童汎髮性膿皰性銀屑病療效好,安全性高,可以作為治療兒童汎髮性膿皰性銀屑病的首選藥物。
목적:탐토아유A치료인동범발성농포성은설병적유효성급안전성。방법회고성분석응용아유A치료18례범발성농포성은설병환인적림상자료급수방정황。결과아유A치료적유효솔위100%,50%적환인우용약1개월체도림상전유,기효시간위1~2주。불량반응이피부소양급점막간조최위상견(77.8%),기차위간매이상(33.3%)、혈지승고(33.3%)、갑취성증가급갑구염(16.7%)、탈발(5.6%),수방기간미발현골격계통이상。복발원인이감염최위상견。결론아유A치료인동범발성농포성은설병료효호,안전성고,가이작위치료인동범발성농포성은설병적수선약물。
ObjectiveTo investigate the efifcacy, side effects and safety of oral acitretin in the treatment of childhood generalized pustular psoriasis.MethodsEighteen cases of generalized pustular psoriasis who hospitalized in the Department of dermatology of Beijing Children’s Hospital were collected. The efficacy and safety of acitretin were analyzed retrospectively.ResultsThe treatment of Acitretin was considered to be effective in all cases. Clinical cure achieved in 50% cases in the ifrst month of treatment. The most common adverse effects were itch and mucocutaneous effects that presented in 77.8% patients during treatment, followed by hepatotoxicity(33.3%), hyperlipidemia(33.3%), paronychia(16.7%) and alopecia(5.6%), no skeletal system abnormalities were found during the follow-up period. The most common predisposing factor of recurrence was infection.ConclusionAs monotherapy, Acitretin is effective and safe for pediatric generalized pustular psoriasis and can be used as the ifrst choice treatment of the disease.